EquityZen Growth Technology Fund LLC - Series 2143
Raised
$750K
Investors
34
Min Invest
$7,689
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2143 is a Delaware-registered pooled investment fund filed by EquityZen Advisors LLC and Phil Haslett. The entity raised $750K from 34 investors with an $8K minimum investment under Rule 506(b) and 3(c) exemptions. It is part of the EquityZen platform, which operates nearly 1,900 pre-IPO investment vehicles.
This pre-IPO pooled fund uses the standard 506(b)/3(c) exemption structure typical of EquityZen's series SPV model. The $8K minimum and sub-$1M raise reflect the platform's retail-accessible approach to secondary market access for private company shares, consistent with other series vehicles in the family.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
